中文
English
한국어
日本語
Español
Français
Русский
| カタログ番号 | HB996046 |
|---|---|
| 説明 |
Blinatumomab (HB996046) is a research-grade recombinant antibody targeting CD19. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| 種反応性 | Human |
| アプリケーション | ELISA, Bioactivity: FCM, Functional assay, Research in vivo |
| 宿主種 | Mouse |
| クローン性 | Monoclonal |
| アイソタイプ | (scFv-kappa-heavy)-(scFv-heavy-kappa) |
| ターゲット | B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, CD3E, CD3e, T-cell surface antigen T3/Leu-4 epsilon chain, T-cell surface glycoprotein CD3 epsilon chain, T3E |
| エンドトキシンレベル | < 10 EU/mg |
| 純度 | >95% as determined by SDS-PAGE. |
| 精製 | Purified by Nickel column. |
| アクセッション番号 | P15391 & P07766 |
| 形態 | Liquid |
| 保存バッファー | 30 mM Histidine, pH5.8, 10% sucrose, 0.02% Tween80 データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。 |
| 安定性と保存 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 別名 | Bispecific, CD19, AMG103, BITEMT-103, MEDI-538, MT103, bscCD19xCD3, 853426-35-4 |
| 背景 | Blinatumomab (Anatumomab) is a bispecific monoclonal antibody with two binding sites, one for CD3E on T cells and one for CD19 on B cells. Blinatumomab can be used in research for acute lymphoblastic leukemia. |
| 注意事項 | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype Control | BiTE Format Isotype Control for Bispecific Reference Antibody (HP473013) |
SDS-PAGE for Anti-Human CD19 & CD3 epsilon Bispecific Reference Antibody (Blinatumomab, RUO)
SEC-HPLC detection for Research Grade Blinatumomab.
+86-027-65523339
中国武漢市深敦寺路666号C棟、武漢、430206
